Brain Tumor Treatments: Canada
Sponsored By
Cleveland ClinicBrain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details

[Click HERE to print this page!]
Braintumor Website

Search Term: Canada
Please scroll down to see the matching trials.

  (0.9474)   RSR-13
  (0.9474)   RSR-13
  (0.9474)   RSR-13
  (0.9352)   Brain Tumor Treatments: Canada
  (0.9017)   Brainstem Glioma
  (0.8792)   Medulloblastoma
  (0.8658)   Ependyoma
  (0.8658)   Pediatric Brain Tumors
  (0.8351)   Links (webTV version)
  (0.8169)   REOLYSIN®
  (0.7967)   Online Support Groups
  (0.7967)   Advanced Search
  (0.7967)   Chemosensitivity For Oligodendrogliomas
  (0.7967)   Online Support Groups
  (0.7967)   Links to More Brain Tumor Information
  (0.7742)   Untitled Document
  (0.7742)   Brain Tumor Centers
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Virtualtrials Survery Results
  (0.7742)   Low Grade Glioma
  (0.7742)   Brain Tumor Chat room
  (0.7742)   Gliosarcoma
  (0.7742)   Brain Tumor Centers
  (0.7742)   Treatments By Geographical Area
  (0.7742)   Prayer and positive thoughts list
  (0.7742)   PCV For Brain Tumors: Abstracts
  (0.7742)   Chat Transcript: Dr. Patel
  (0.7742)   Oligodendroglioma High Grade
  (0.7742)   Brain Tumor Centers
  (0.7742)   Brain Tumor Organizations
  (0.7742)   Anaplastic Astrocytoma
  (0.7742)   Anaplastic Astrocytoma
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Metastatic Brain Tumor
  (0.7742)   Metastatic Brain Tumor
  (0.7742)   Any Malignant Brain Tumor
  (0.7742)   Braintumor Support Group Survey
  (0.7742)   Braintumor Support Group Survey

Sorry - There were no pages found that contain that search phrase.



  Treatment Location Last Updated
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Halifax, Nova Scotia, Canada 03/01/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Edmonton, Alberta, CANADA 03/01/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Winnipeg, Manitoba, CANADA 03/01/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Moncton, New Brunswick, CANADA 03/01/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Ottawa, Ontario, CANADA 03/01/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Toronto, Ontario, CANADA 03/01/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Kingston, Ontario, CANADA 03/01/2008
Details A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas Toronto, Ontario, CANADA 08/26/2007
Details A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients Toronto, Ontario, CANADA 08/26/2007
Details The Temozolomide RESCUE Study: A Phase II Trial of Continuous (28/28) Dose-Intense Temozolomide (CDIT) Chemotherapy After Progression on Conventional 5/28 Day Temozolomide in Patients With Recurrent Malignant Glioma Toronto, Ontario, CANADA 08/20/2007
Details A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas. Montreal, Canada 08/18/2007
Details Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Hamilton, Canada 08/18/2007
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) , Canada 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) , Canada 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) , Canada 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) , Canada 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) , Canada 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) , Canada 10/12/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma , Canada 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma , Canada 05/30/2006
Details Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma Toronto, Ontario, , CANADA 05/21/2006
Details A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour Edmonton, Alberta, Canada 05/04/2006
Details Comparative 2-D Tumor Analysis in Familial Gliomas Edmonton, Alberta, Canada 05/04/2006
Details Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery Toronto, Ontario, Canada 01/08/2006
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Hamilton, Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma , Canada 11/27/2005
Details Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Gliobastoma Treated With Concurrent Radiation Therapy and Temozolomide Edmonton, Alberta, Canada 11/27/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors , Canada 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Hamilton, Canada 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors , Canada 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors , Canada 11/26/2005
Details FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia , CANADA 11/11/2005
Details Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors , CANADA 11/11/2005



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Gliadel® Wafer | Temodar®
Fundraising For Research | Unsubscribe | Feedback | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE

Copyright (c) 1993 - 2008 by The Musella Foundation

Website Design By
World Wide Websites